Business Wire

Ardian Set to Mobilize Development Finance Institutions (DFIs) With European Investment Bank (EIB), Proparco and British International Investment (BII) for a €100m Commitment for Its Nature-Based Solutions Strategy

12.11.2025 17:12:00 CET | Business Wire | Press Release

Share

Ardian, a world-leading private investment firm, today announces that it has secured commitment from several Development Finance Institutions (DFIs), the European Investment Bank (EIB) and Proparco. British International Investment (BII) have signaled their intention to provide commitment to the Nature Based Solutions fund. Total fund commitments will stand for a total of c. €100m by year end to Ardian’s Nature-Based Solutions (NBS) strategy. As anchor investors, EIB’s development arm EIB Global commits €50m, while Proparco will commit €20m and British International Investment has received approval for a €10m commitment, subject to final negotiations.

Averrhoa NBS is a SFDR1 Article 9 impact fund overseen by Ardian’s Infrastructure team in partnership with aDryada, a specialist developer and manager of large-scale ecosystem restoration projects. The strategy is dedicated to investing in projects to reforest and restore wetlands and mangroves, intended to protect biodiversity while enabling the sequestration of large volumes of carbon from the atmosphere via natural carbon sinks. The strategy aims to sequester 85 million tons of carbon over a period of 40 years2. These anchors investors, including FDJ UNITED for €5m and Mutuelle d’Ivry (La Fraternelle), will allow the fund to secure a €100m first round of commitment, and to attract institutional investors and corporate seeking to have positive environmental and social impact through their investment activities.

As well as sequestering carbon, Averrhoa NBS projects will seek to contribute to climate mitigation by preserving water resources and improving soil and air quality. The aim is to rebuild ecosystems and to protect natural habitats and biodiversity through richer and stronger ecosystems, as well as bringing sustainable income and investments in social infrastructures to local economies.

Over 50% of global GDP depends on healthy ecosystems, yet biodiversity loss is threatening economic stability, warns the World Bank. Forests are vanishing at 5 million hectares a year, while rising temperatures make the 1.5°C target harder to reach and are driving unprecedented species loss, endangering food security, climate resilience, water access, and public health.3 Ardian is contributing to address these challenges by developing high‑integrity, nature‑based carbon capture projects that also intend to restore biodiversity, benefit local communities, and support growing demand for credible net‑zero solutions.

Ardian strives to address a shortage of projects in this area. Large buyers are prioritizing nature-based solutions projects to achieve net zero due to their potential to restore biodiversity and create benefits for local communities.

Ardian’s NBS team has built a robust pipeline across Latin America, Africa and Asia through the careful selection of developers. Key criteria for project selection include a strong track record, a local team equipped for stringent monitoring, and advanced offtake discussions.

The NBS strategy forms a central part of Ardian’s broader decarbonization agenda. This track record includes financing 8.2GW of heat and renewable energy and its €2bn Hy24 hydrogen infrastructure fund. Ardian also provides capital solutions to companies committed to reducing their carbon footprint, with 11,000 portfolio companies committed to Science-based Target Initiative (SBTI) to support global net-zero target.

“This first €100m round of commitments marks a milestone in Ardian’s journey to becoming a -leading player in nature restoration projects. On top of targeting the sequestration of 85 million tons of carbon, the fund aims to play a significant role in restoring ecosystems, protecting biodiversity, while benefiting local communities. We are very grateful to our anchor investors for their confidence in Ardian’s world-class Infrastructure and NBS investment expertise.”

  • LAURENT FAYOLLAS - MEMBER OF THE EXECUTIVE COMMITTEE AND DEPUTY HEAD OF INFRASTRUCTURE, ARDIAN

“This fund represents an important step forward in scaling nature-based solutions across emerging markets. We are helping to address climate change, protect biodiversity and improve the livelihoods of local communities. This investment reflects our commitment to mobilizing public and private capital for environmental protection and sustainable development.”

  • AMBROISE FAYOLLE - VICE PRESIDENT, EIB

“As part of Proparco’s Natural Capital strategy, we are proud to partner with Ardian, aDryada, and the EU CarbonSinks Programme to support long-term investments in high-quality afforestation, reforestation, and revegetation projects. These initiatives will remove carbon from the atmosphere while also delivering strong climate, biodiversity, and socio-economic benefits for local communities.”

  • JEAN-BAPTISTE SABATIÉ - DEPUTY CHIEF EXECUTIVE OFFICER, PROPARCO

“Supporting nature-based solutions is central to climate mitigation and adaptation, a cornerstone of BII’s climate strategy. At COP30, we reaffirm our commitment to mobilising capital for high impact projects that restore ecosystems and build climate resilience in emerging markets because tackling the climate emergency requires both innovation and scale.”

  • LESLIE MAASDORP - CHIEF EXECUTIVE OFFICER, BRITISH INTERNATIONAL INVESTMENT

With Ardian clients and institutional investors increasingly prioritizing their contributions to biodiversity protection, Ardian’s Nature-Based Solutions strategy offers opportunities to invest in projects intended to enhance biodiversity, restore large-scale depleted ecosystems and support local economies.

Important notice: This press release is provided for information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities or interests in any fund. Investments in private equity involve risks, including the risk of partial or total loss of capital. Any investment decision should be made solely on the basis of the fund’s official offering documentation. The fund referenced herein is intended exclusively for professional investors within the meaning of Directive 2014/65/EU or equivalent investor categories under the laws of the relevant jurisdictions.

1 Regulation (EU) 2019/2088 of the European Parliament and of the Council of 27 November 2019 on sustainability‐related disclosures in the financial services sector. The European Union sustainable-finance rules are still evolving. Hence, it cannot be excluded that future changes in law or guidance may not support the Fund’s current categorization under SFDR

2 Indicative figures based on current pipeline of project. Post ramp-up phase and assuming 40 years project life.
3 Damania, Richard; Ebadi, Ebad; Mayr, Kentaro; Russ, Jason; Zaveri, Esha. Reboot Development: The Economics of a Livable Planet. Washington, DC: World Bank, 2025.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251112657727/en/

Contacts

Media Contacts
ARDIAN
HEADLAND
ardian@headlandconsultancy.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press Release

Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechnology executive, bringing over two decades of therapeutic and diagnostic R&D experience within industry to Mosaic Therapeutics, with a track record spanning from IND through to NDA/BLA/MAA approval. Most recently he served at BioXcel Therapeutics as EVP, Head of Product Developme

The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 09:00:00 CEST | Press Release

The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights - equipping executives with the perspective needed to make confident, high-stakes decisions. “Through our work we increasingly s

Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 08:00:00 CEST | Press Release

As millions of Europeans2 get ready to enjoy the Easter weekend, new research from Samsung finds Europe’s public spaces have become shared screens: 56% of people say they have accidentally looked at a stranger’s phone, citing public transport as the most likely place to notice someone else’s screen (57%). Nearly one in four Europeans2 (24%) admit to looking at someone else’s phone out of curiosity, exposing a stream of private content from personal photos to bank details. Samsung Electronics surveyed 11,000 Europeans2 to support the launch of the Galaxy S26 Ultra, which introduces a built-in Privacy Display. This new hardware-based technology keeps screen content visible only from the front to protect privacy from side angles, without compromising the viewing experience3. The study further reveals a gap between perceived phone privacy and reality: While 48%* feel their own phone use is private when using it in crowded places, 52%** find it easy to view someone else’s screen in public.

RevolKa Reimagines Antibody Engineering with "RevoAb ® "1.4.2026 06:30:00 CEST | Press Release

RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allows researchers worldwide to experience RevolKa’s high-performance antibody design. Key Advantages of RevoAb® Speed: Multiple optimi

Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 03:00:00 CEST | Press Release

NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales, reshaping channel strategies 49% of consumers are willing to pay more for locally made products, ref

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye